EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT)
CUSIP: 30233G209
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 82,695,711
- Total 13F shares
- 88,510,777
- Share change
- +5,469,161
- Total reported value
- $1,140,946,335
- Put/Call ratio
- 35%
- Price per share
- $12.89
- Number of holders
- 184
- Value change
- +$42,505,333
- Number of buys
- 113
- Number of sells
- 60
Quarterly Holders Quick Answers
What is CUSIP 30233G209?
CUSIP 30233G209 identifies EYPT - EyePoint, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 30233G209:
Top shareholders of EYPT - EyePoint, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
13F
13D/G
3/4/5
|
Company · Former 10% Owner |
10%
from 13D/G
|
8,265,000
|
$151,001,550 | — | 31 Dec 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
9.5%
|
7,827,685
|
$143,011,805 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.5%
from 13D/G
|
6,787,872
|
$124,014,422 | — | 31 Dec 2025 | |
| FEDERATED HERMES, INC. |
13F
13D/G
|
Company |
6.7%
from 13D/G
|
6,017,433
|
$109,938,500 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
13D/G
|
Company |
6.1%
from 13D/G
|
4,976,915
|
$90,928,238 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
4,822,139
|
$88,100,480 | — | 31 Dec 2025 | |
| EW Healthcare Partners, L.P. |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
3,490,921
|
$87,327,483 | — | 01 Sep 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
5.7%
|
4,700,000
|
$85,869,000 | — | 31 Dec 2025 | |
| Paradigm Biocapital Advisors LP |
13F
13D/G
|
Company |
3.8%
from 13D/G
|
3,691,475
|
$67,443,248 | — | 31 Dec 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
4.3%
|
3,572,335
|
$65,266,560 | — | 31 Dec 2025 | |
| TCG Crossover GP II, LLC |
13D/G
|
— |
4.3%
|
3,572,335
|
$62,265,799 | $0 | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.6%
|
2,937,729
|
$53,657,620 | — | 31 Dec 2025 | |
| Adage Capital Management, L.P. |
13D/G
3/4/5
|
10%+ Owner |
4%
|
3,300,000
|
$46,827,000 | -$19,866,000 | 31 Mar 2026 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3%
|
2,468,314
|
$45,096,097 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,899,367
|
$34,709,656 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
1,834,850
|
$33,522,710 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.9%
|
1,605,984
|
$29,341,328 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
1,249,757
|
$22,833,061 | — | 31 Dec 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
4.7%
|
3,181,818
|
$20,809,090 | $0 | 31 Dec 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.3%
|
1,088,033
|
$19,878,363 | — | 31 Dec 2025 | |
| Essex Woodlands Management, Inc. |
13F
|
Company |
1.3%
|
1,084,857
|
$19,820,336 | — | 31 Dec 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.3%
|
1,050,000
|
$19,183,500 | — | 31 Dec 2025 | |
| Spruce Street Capital LP |
13F
|
Company |
1.2%
|
981,543
|
$17,932,791 | — | 31 Dec 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.95%
|
784,403
|
$14,331,043 | — | 31 Dec 2025 | |
| Patient Square Capital LP |
13F
|
Company |
0.94%
|
780,000
|
$14,250,600 | — | 31 Dec 2025 | |
| Artia Global Partners LP |
13F
|
Company |
0.93%
|
767,098
|
$14,014,880 | — | 31 Dec 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.83%
|
690,000
|
$12,606,300 | — | 31 Dec 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.82%
|
674,395
|
$12,321,721 | — | 31 Dec 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.8%
|
661,452
|
$12,084,727 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
648,565
|
$11,849,283 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.72%
|
595,392
|
$10,877,812 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
577,586
|
$10,552,496 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.67%
|
556,469
|
$10,166,689 | — | 31 Dec 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.66%
|
544,077
|
$9,940,287 | — | 31 Dec 2025 | |
| Principia Wealth Advisory, LLC |
13F
|
Company |
0.64%
|
530,725
|
$9,696,346 | — | 31 Dec 2025 | |
| Nancy Lurker |
3/4/5
|
Director |
—
mixed-class rows
|
488,505
mixed-class rows
|
$7,696,047 | -$150,942 | 06 Jan 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.5%
|
416,100
|
$7,602,154 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.49%
|
402,063
|
$7,343,545 | — | 31 Dec 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.47%
|
392,594
|
$7,172,692 | — | 31 Dec 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.45%
|
375,264
|
$6,856,073 | — | 31 Dec 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.44%
|
366,675
|
$6,699,152 | — | 31 Dec 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.43%
|
353,849
|
$6,464,821 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.41%
|
339,004
|
$6,193,603 | — | 31 Dec 2025 | |
| Bleichroeder LP |
13F
|
Company |
0.38%
|
316,515
|
$5,782,729 | — | 31 Dec 2025 | |
| MYDA Advisors LLC |
13F
|
Company |
0.36%
|
300,000
|
$5,481,000 | — | 31 Dec 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.31%
|
258,739
|
$4,727,162 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
256,743
|
$4,690,689 | — | 31 Dec 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.3%
|
246,279
|
$4,500,000 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.27%
|
226,770
|
$4,143,088 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.27%
|
223,699
|
$4,086,982 | — | 31 Dec 2025 |
Institutional Holders of EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT) as of Q1 2026
As of 31 Mar 2026,
EyePoint, Inc. - Common Stock, $0.001 par value per share (EYPT) was held by
184 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,510,777 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, Cormorant Asset Management, LP, BlackRock, Inc., FEDERATED HERMES, INC., FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, VANGUARD CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Paradigm Biocapital Advisors LP, and Commodore Capital LP.
This page lists
184
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
164
Q1 2026 holders
184
Holder diff
20
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.